The absence of a tiny, abundant liver-specific microRNA (miRNA) molecule may lead to liver cancer, say researchers who tested the idea in mice and write about their findings in a paper published online this week in the Journal of Clinical Investigation. They suggest their findings show it may be possible to develop a treatment that restores the molecule, miR-122, in some patients with liver cancer, an often fatal disease for which there are few treatments...
More...
More...